" class="no-js "lang="en-US"> Lynk Pharmaceuticals Archives - Medtech Alert
Thursday, March 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Lynk Pharmaceuticals Announces First Cohort of Psoriatic Patients Dosed with LNK01004

Lynk Pharmaceuticals, an innovative clinical stage company, announced that it has dosed the first cohort […]

Lynk's LNK01001 Achieved Exciting Phase II Results in Rheumatoid Arthritis

Lynk Pharmaceuticals, an innovative clinical-stage company, announced that the Phase II clinical trial of LNK01001 […]

Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects

Lynk Pharmaceuticals, an innovative clinical-stage company, announced that it has recently completed phase I trials […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more